Simon Lu
Directeur/Membre du Conseil chez ASCENTAGE PHARMA GROUP INTERNATIONAL
Fortune : - $ au 31/05/2024
Profil
Simon Dazhong Lu is a Non-Executive Director at Ascentage Pharma Group International Co., Ltd.
He was previously a Director at McGill University, Managing Director at CEL Partners Co. Ltd., and Partner & Investment Manager at Shanghai NewMargin Ventures Investment Management Co. Ltd.
He also worked as an Auditor at Arthur Andersen Business Consulting Co. Ltd.
(Shanghai).
Lu holds a doctorate degree from Nankai University, which he received in 2010, and an undergraduate degree from the same university, which he received in 1991.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2023 | 0 ( -.--% ) | - $ | 31/05/2024 |
Postes actifs de Simon Lu
| Sociétés | Poste | Début |
|---|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Directeur/Membre du Conseil | 06/07/2018 |
Anciens postes connus de Simon Lu
| Sociétés | Poste | Fin |
|---|---|---|
| McGill University | Directeur/Membre du Conseil | 01/11/2018 |
CEL Partners Co. Ltd.
 CEL Partners Co. Ltd. Investment ManagersFinance CEL Partners is an independent China-based private equity firm which was established in 2007 to manage China Equity Links SAS, the first independent continental Europe private equity fund dedicated to investments in China. Based in Beijing, CEL Partners is comprised of Chinese and Western professionals, complemented by a team of Senior Advisors. The China Equity Links fund is backed by global financial institutions including Crédit Agricole, Société Générale, Caisse des Dépôt et des Consignations, Savings Bank Group, CNP, Groupama and Scor and has an office in Paris, France. | Directeur Général | 01/07/2009 |
Shanghai NewMargin Ventures Investment Management Co. Ltd.
 Shanghai NewMargin Ventures Investment Management Co. Ltd. Investment ManagersFinance Shanghai NewMargin Ventures Investment Management Co. Ltd. is an Independent Venture Capital firm founded in 1999 by Tao Feng. Shanghai NewMargin Ventures Investment Management Co. Ltd. is headquartered in Shanghai. | Directeur en chef des Investissements | 01/12/2007 |
| Arthur Andersen Business Consulting Co. Ltd. (Shanghai) | Comptroller/Controller/Auditor | - |
Formation de Simon Lu
| Nankai University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Health Technology |
| Entreprise privées | 3 |
|---|---|
CEL Partners Co. Ltd.
CEL Partners Co. Ltd. Investment ManagersFinance CEL Partners is an independent China-based private equity firm which was established in 2007 to manage China Equity Links SAS, the first independent continental Europe private equity fund dedicated to investments in China. Based in Beijing, CEL Partners is comprised of Chinese and Western professionals, complemented by a team of Senior Advisors. The China Equity Links fund is backed by global financial institutions including Crédit Agricole, Société Générale, Caisse des Dépôt et des Consignations, Savings Bank Group, CNP, Groupama and Scor and has an office in Paris, France. | Finance |
Shanghai NewMargin Ventures Investment Management Co. Ltd.
Shanghai NewMargin Ventures Investment Management Co. Ltd. Investment ManagersFinance Shanghai NewMargin Ventures Investment Management Co. Ltd. is an Independent Venture Capital firm founded in 1999 by Tao Feng. Shanghai NewMargin Ventures Investment Management Co. Ltd. is headquartered in Shanghai. | Finance |
| Arthur Andersen Business Consulting Co. Ltd. (Shanghai) |
